Card View

Expanded Access for Iberdomide Expanded Access

Available
Brief Summary
This is an expanded access designed to provide access to Iberdomide for eligible participants.
Other Study IDs
  • IM048-1093
NCT ID Number
Last Update Posted
2026-02-27
Study Type
Expanded access
Status
Available
Arms / Interventions
Participant Group/ArmIntervention/Treatment
N/A
Iberdomide
Participation Assistant
Eligibility Criteria

Eligible Ages
Child, Adult, Older Adult

-

-
Bristol-Myers Squibb logoBristol-Myers Squibb
Study Central Contact
Contact: BMS Clinical Trials Contact Center www.BMSClinicalTrials.com, 855-907-3286, [email protected]
Contact: First line of the email MUST contain the NCT# and Site #.
No location data.